Enhanced Recovery After Surgery (ERAS) Protocol in Faciomaxillary Fractures at a Tertiary Care Hospital
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2026
Project Lead
Dr Omkar Gutta (MCh Resident)
Authors
Dr Omkar & Dr Abha Rani Kujur
Project Status
ongoing
Project Type
Randomized controlled trial